Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
InMed Pharmaceuticals Inc
INM
Healthcare
Cannabis
InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare...
cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:INM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 25, 2022 7:30am
New Press Release - InMed Announces Update on Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosa
Phase 2 clinical trial recently expanded to include adolescents following independent review of early safety dataFirst adolescent patient with EB enrolled into clinical trial and completed treatment International patent granted for the use of cannabinol for the treatment of epidermolysis bullosa ...
read article.
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 24, 2022 8:36am
List of Cannabinoids
https://www.newphaseblends.com/list-of-cannabinoids/
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 18, 2022 7:30am
New Press Release - InMed Announces Appointment of Chief Operating Officer
VANCOUVER, British Columbia, July 18, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announces Michael Woudenberg has been appointed Chief...
read article.
(2)
•••
JakeVegas
X
View Profile
View Bullboard History
Comment by
JakeVegas
on Jul 15, 2022 9:25am
RE:Volume Spike InMed On the Move
Yes it spiked to a new year low. Great analysis on this dumpster fire
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 14, 2022 12:36pm
Volume Spike InMed On the Move
$INM InMed +27% and seems to be on the move today & volume coming in as well!
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 14, 2022 12:34pm
Volume Spike along with SP
Just noticed a big spike in volume. Apparently, there is huge demand for D9 THCV. https://finance.yahoo.com/quote/INM/
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 13, 2022 11:45am
D9 THCV Sale
https://lulacbd.shop/products/d9-thcv-isolate
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 12, 2022 11:33pm
New Press Release - InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
VANCOUVER, British Columbia, July 12, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a research, development, manufacturing corporation specializing in the commercialization of rare cannabinoids, announces that, as previously disclosed pursuant to a...
read article.
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 09, 2022 9:20am
Pharma Blue Sky
Skip to 45:00 https://youtu.be/ngaeP7dUtp8
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 07, 2022 10:32pm
Pharma Biotech M&As Have Started
https://www.reuters.com/markets/deals/merck-advanced-talks-buy-seagen-40-billion-deal-wsj-2022-07-07/
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 05, 2022 10:49pm
Growth Over the Next 10 years
https://youtu.be/AssQAYmOo0I
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 01, 2022 7:51am
InMed Stocktwits Post
targatrader 6/30/22, 10:57 PM $INM is in the same position as $REVB was today. They had their S-/A TUTE offering announced a month ago and BOOMit explodes higher by 300%. It has been around the same
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Comment by
Bullknit101
on Jul 01, 2022 7:47am
RE:Biotech Stocks
https://www.marketwatch.com/story/seven-reasons-the-beleaguered-biotech-sector-is-now-a-buy-11655475446
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jul 01, 2022 12:03am
Biotech Stocks
https://www.ft.com/content/bfd7d96f-2af9-4614-b1eb-78949365de9a
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jun 28, 2022 7:50pm
News Wednesday ?
https://stocktwits.com/symbol/INM
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income